FWD1802 is named as a drug or biological intervention in 3 clinical trials in our China trial register, 2 of which are recruiting. The lead sponsor is Forward Pharmaceuticals Co., Ltd.. Registered phases: Phase 1/2 and Phase 1. Conditions studied include Metastatic Breast Cancer; Breast Cancer Stage I; Breast Cancer Stage II.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06064812 | A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC. (ClinicalTrials.gov ↗) Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage IV |
Phase 1/2 | Recruiting |
| NCT07002177 | A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC (ClinicalTrials.gov ↗) Metastatic Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II |
Phase 1/2 | Recruiting |
| NCT07476963 | Evaluation of the Food Effecton the Pharmacokinetics of FWD1802 in Healthy Subjects (ClinicalTrials.gov ↗) Healthy |
Phase 1 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Metastatic Breast Cancer | 2 |
| Breast Cancer Stage I | 1 |
| Breast Cancer Stage II | 1 |
| Locally Advanced Breast Cancer (LABC) | 1 |
| Locally Advanced Breast Cancer | 1 |
| Breast Cancer Stage IV | 1 |
| ER+/HER2- Breast Cancer | 1 |
| Healthy | 1 |
| Lead sponsor | Trials |
|---|---|
| Forward Pharmaceuticals Co., Ltd. | 3 |
| Register | FWD1802 trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how FWD1802 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists FWD1802 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.